Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
MAGLE.STthis companyMagle Chemoswed Holding AB (publ)	SEK 0.26	-2.27×	0.92×	1.28×	-28.7×	-13592.2%	82.2%	-48.1%	-56.5%	-40.4%	-16.7%	-12.2%	0.87×	-13.71×	-3.5×	1.37×	0.0%	3	-0.62	2	C
ACE.STAscelia Pharma AB (publ)	SEK 0.54	-4.81×	3.67×	0×	-4.32×	-17.7%	0.0%	0.0%	0.0%	-76.7%	-73.4%	-19.8%	0.01×	0.67×	-13.46×	4.35×	0.0%	1	-8.91	2	C+
BIOWKS.STBio-Works Technologies AB (publ)	SEK 3.17	-15.41×	4.64×	3.66×	-11.76×	-1411.9%	76.5%	-28.0%	-24.4%	-31.0%	-31.6%	-8.4%	0×	2.12×	-90.77×	3.2×	0.0%	4	16.39	2	C
CLBIO.STCorline Biomedical AB	SEK 12.80	-27.8×	4.33×	53.02×	-27.26×	-165.9%	-185.7%	-185.7%	-192.3%	-15.7%	-15.2%	-4.4%	0×	1.46×	0×	4.98×	0.0%	3	12.35	1	D+
ELIC.STElicera Therapeutics AB (publ)	SEK 2.60	-13.74×	10.19×	0×	-12.25×	-80.7%	0.0%	0.0%	0.0%	-74.5%	-76.8%	-9.1%	0×	1.43×	-2,278.11×	6.75×	0.0%	1	32.08	1	C-
IMMU.STMendus AB (publ)	SEK 5.23	-2.58×	0.5×	0×	-2.16×	-84.5%	0.0%	0.0%	0.0%	-19.4%	-19.9%	-28.0%	0.03×	0.4×	-36.63×	2.7×	0.0%	1	-0.16	2	B-
Peer median	—	-13.74×	4.33×	0×	-11.76×	-84.5%	0.0%	0.0%	0.0%	-31.0%	-31.6%	-9.1%	0×	1.43×	-36.63×	4.35×	0.0%	1	12.35	2	—